Tobramycin + FluorometholoneThird Party Manufacturing in India

Tobramycin + Fluorometholone works by combining an antimicrobial mechanism with an anti-inflammatory pathway. Tobramycin inhibits bacterial protein synthesis through 30S ribosomal binding to kill ocular pathogens, while Fluorometholone suppresses the migration of polymorphonuclear leukocytes and reverses capillary permeability to limit edema. Unlike stronger steroids, Fluorometholone carries a much lower risk of elevating intraocular pressure during short-term therapeutic regimens. It is highly effective and well-tolerated.

Therapeutic Uses

• Steroid-Responsive Ocular Inflammations: Treats conditions where bacterial infection exists or where there is an explicit risk of superficial bacterial eye infection.
• Post-Operative Inflammation: Controls post-surgical swelling and prevents opportunistic bacterial colonization following cataract procedures.

Why Manufacturers Choose Tobramycin + Fluorometholone

Ophthalmic specialists favor this exact combination due to the safety profile of Fluorometholone compared to dexamethasone. Investing in Tobramycin + Fluorometholone third party manufacturing in India lets companies target safety-conscious medical professionals. Our partner production facilities are WHO-GMP certified and apply advanced micro-suspension techniques to prevent crystal agglomeration of the steroid components under primary CAS number 32986-56-4.